Search research articles
Contact Us
Filters
Showing results (541-550 of 711) with videos related to
Page
of 72
Sort By:
The American Journal of Clinical Nutrition
|
August 30, 2022
An agent-based model of child sugar-sweetened beverage consumption: implications for policies and practices
Matt Kasman, Ross A Hammond, Rob Purcell, et al.
Annals of Epidemiology
|
September 8, 2012
The PhenX Toolkit pregnancy and birth collections
Nedra S Whitehead, Jane A Hammond, Michelle A Williams, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 26, 2011
Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip
Michael Lock, Jeffrey Q Cao, David P D'Souza, et al.
BMJ Open
|
August 8, 2015
Protocol for a randomised controlled trial for Reducing Arthritis Fatigue by clinical Teams (RAFT) using cognitive-behavioural approaches
S Hewlett, N Ambler, C Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer
Anthony W Tolcher, John Kuhn, Garry Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial
Malcolm Ranson, Lisa A Hammond, David Ferry, et al.
Journal of the American Society of Nephrology : JASN
|
August 3, 2013
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy
Yuzhou Zhang, Carla M Nester, Danniele G Holanda, et al.
American Journal of Preventive Medicine
|
December 12, 2022
Understanding Misimplementation in U.S. State Health Departments: An Agent-Based Model
Matt Kasman, Ross A Hammond, Rob Purcell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies
Johann S de Bono, Joseph Stephenson, Sharyn D Baker, et al.
Mbio
|
March 14, 2019
Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket
Pierrick Craveur, Anna T Gres, Karen A Kirby, et al.
Page
of 72
Search research articles
Search
Showing results (541-550 of 711) with videos related to
Sort By:
Page
of 72
The American Journal of Clinical Nutrition
|
August 30, 2022
An agent-based model of child sugar-sweetened beverage consumption: implications for policies and practices
Matt Kasman, Ross A Hammond, Rob Purcell, et al.
Annals of Epidemiology
|
September 8, 2012
The PhenX Toolkit pregnancy and birth collections
Nedra S Whitehead, Jane A Hammond, Michelle A Williams, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 26, 2011
Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip
Michael Lock, Jeffrey Q Cao, David P D'Souza, et al.
BMJ Open
|
August 8, 2015
Protocol for a randomised controlled trial for Reducing Arthritis Fatigue by clinical Teams (RAFT) using cognitive-behavioural approaches
S Hewlett, N Ambler, C Almeida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer
Anthony W Tolcher, John Kuhn, Garry Schwartz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 2002
ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial
Malcolm Ranson, Lisa A Hammond, David Ferry, et al.
Journal of the American Society of Nephrology : JASN
|
August 3, 2013
Soluble CR1 therapy improves complement regulation in C3 glomerulopathy
Yuzhou Zhang, Carla M Nester, Danniele G Holanda, et al.
American Journal of Preventive Medicine
|
December 12, 2022
Understanding Misimplementation in U.S. State Health Departments: An Agent-Based Model
Matt Kasman, Ross A Hammond, Rob Purcell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Troxacitabine, an L-stereoisomeric nucleoside analog, on a five-times-daily schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies
Johann S de Bono, Joseph Stephenson, Sharyn D Baker, et al.
Mbio
|
March 14, 2019
Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket
Pierrick Craveur, Anna T Gres, Karen A Kirby, et al.
Page
of 72